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Introduction
Colorectal cancer (CRC) arises by sequential acquisition of mu-
tations in cells of the intestinal epithelium (Fearon, 2011). Until 
recently, the early steps in this process could not faithfully be 
analyzed in vitro because CRC cell lines are usually derived 
from advanced carcinomas. In contrast, organoids can be estab-
lished from normal tissue and any stage of malignant progres-
sion (Sato et al., 2009, 2011b). Thus, organoids are well suited 
to study oncogene interaction in intestinal cells.
CRC is most frequently initiated by mutations activating 
the Wnt–β-catenin signaling pathway, such as by loss of the 
tumor suppressor and β-catenin regulator adenomatous pol-
yposis coli (APC) or by mutations in β-catenin that prevent 
degradation. These mutations stabilize stem cell fate (Clevers 
et al., 2014). Functional loss of APC and stabilizing mutations 
in β-catenin have similar effects in intestinal organoids (Far-
rall et al., 2012). The phosphatidylinositol-3-kinase (PI3K) 
signaling cascade is often activated during CRC progres-
sion, frequently by hotspot mutations in the catalytic kinase 
subunit PIK3CA (Parsons et al., 2005; The Cancer Genome 
Atlas Network, 2012). Oncogenic PIK3CA operates via the 
kinase AKT, which can directly phosphorylate cytoskeletal 
targets to regulate cell motility and invasion (Xue and Hem-
mings, 2013), the mechanistic target of rapamycin (mTOR) 
complex 1 (mTORC1), which integrates cell signal transduc-
tion, translation, and metabolic regulation (Song et al., 2012), 
and FOXO-type transcription factors (Jacinto et al., 2006; 
Tzivion and Hay, 2011).
The mouse small intestine is a well-established model 
system to interrogate signaling networks relevant for human 
colon cancer. In this study, we used organoids of the mouse 
small intestine to study cooperation of oncogenic Wnt–β- 
catenin and PI3K activities. We found that mutant stabilized 
β-catenin (CTN NB1stab) and PIK3CAH1047R induce multiple 
hallmark traits of cancer that are not immediately apparent in 
2D cell line cultures or in transgenic mouse models. We dis-
covered that the induction of cell attachment and motility via 
PIK3CAH1047R depends on active β-catenin. By using a panel 
of pharmaceutical inhibitors in combination with phenotypic 
assays and phosphoprotein profiling, we link cell survival and 
motility to 4EBP1 and AKT phosphorylation, respectively.
Colorectal cancer is driven by cooperating oncogenic mutations. In this study, we use organotypic cultures derived from 
transgenic mice inducibly expressing oncogenic β-catenin and/or PIK3CAH1047R to follow sequential changes in can-
cer-related signaling networks, intestinal cell metabolism, and physiology in a three-dimensional environment mimicking 
tissue architecture. Activation of β-catenin alone results in the formation of highly clonogenic cells that are nonmotile and 
prone to undergo apoptosis. In contrast, coexpression of stabilized β-catenin and PIK3CAH1047R gives rise to intestinal 
cells that are apoptosis-resistant, proliferative, stem cell–like, and motile. Systematic inhibitor treatments of organoids 
followed by quantitative phenotyping and phosphoprotein analyses uncover key changes in the signaling network topol-
ogy of intestinal cells after induction of stabilized β-catenin and PIK3CAH1047R. We find that survival and motility of or-
ganoid cells are associated with 4EBP1 and AKT phosphorylation, respectively. Our work defines phenotypes, signaling 
network states, and vulnerabilities of transgenic intestinal organoids as a novel approach to understanding oncogene 
activities and guiding the development of targeted therapies.
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Results and discussion
The CTN NB1stab and PIK3CAH1047R 
oncoproteins modulate intestinal organoid 
phenotypes
To study processes after gain of oncogenic mutations in the 
Wnt–β-catenin and PI3K pathways in the intestinal epithelium, 
we generated transgenic mice carrying doxycycline-inducible 
oncogenes coexpressed with the fluorescent marker tdTomato 
in a modified Gt(ROSA26)Sor locus (Fig. 1 A; Vidigal et al., 
2010). Four transgenic mouse lines were used, producing 
CTN NB1stab, PIK3CAH1047R, both oncoproteins together from a 
single transgene to ensure coexpression, or firefly luciferase as a 
negative control (for in vivo phenotypes, see Fig. S1).
To study CTN NB1stab and PIK3CAH1047R in vitro, we cul-
tured intestinal organoids in a 3D Matrigel matrix and crypt 
culture medium (CCM) containing the growth factors R-spon-
din, EGF, and noggin (CCM-REN; Sato et al., 2011b). A mod-
ified medium lacking the Wnt cofactor R-spondin (CCM-EN) 
was used to select for organoid cells producing CTN NB1stab 
alone or CTN NB1stab–PIK3CAH1047R. These represent the rel-
evant oncogene combinations in CRC progression: β-catenin 
activation triggers adenoma formation, whereas the con-
version to carcinoma frequently involves activation of both 
β-catenin and PI3KCA, among other alterations (The Cancer 
Genome Atlas Network, 2012).
In CCM-EN, CTN NB1stab-induced cultures grew out as 
spheroids, devoid of crypt–villus organization (Fig. 1 B; Far-
rall et al., 2012). The CTN NB1stab–PIK3CAH1074R combination 
resulted in the formation of mixed phenotypes comprising or-
ganoids, spheroids, and colonies growing in 2D on the plastic 
surface. In contrast, PIK3CAH1047R organoids died in CCM-EN.
Transcriptome analysis of CTN NB1stab and 
PIK3CAH1047R in intestinal cells
We first analyzed transcriptomes after induction of the on-
coproteins. CTN NB1stab induced or repressed 895 genes 
compared with 245 for PIK3CAH1047R, and the combination 
of both oncoproteins regulated 784 additional genes (Fig. 1, 
C and D). We clustered the 1,000 most variable genes and 
annotated the clusters by gene ontology (Fig. 1 E; Huang et 
al., 2009). Clusters 2 and 3, repressed the most by the on-
coprotein combination, were enriched for apoptosis regula-
tors such as Bcl2l11. Clusters 4 and 5 were defined by genes 
promoting DNA replication and cell cycle progression. 
Cluster 4, induced specifically by CTN NB1stab, included Myc 
and the stem cell marker Lgr5. Cluster 5, induced by both 
PIK3CAH1047R and CTN NB1stab, was enriched for cyclin and 
aurora kinase genes. Cluster 6 revealed a focus on protein 
biosynthesis, with many genes encoding tRNA synthases 
and ribosomal components.
We assigned molecular functions to the oncoproteins 
by gene set enrichment analysis (GSEA; Fig.  1  F; Subrama-
nian et al., 2005). CTN NB1stab and PIK3CAH1047R specifically 
induced hallmark signatures comprising Wnt–β-catenin– and 
PI3K-AKT-mTOR–responsive genes, respectively. Both on-
coproteins, alone and in combination, activated proliferation 
signatures comprised of MAPK targets (Jürchott et al., 2010), 
E2F targets, or mitosis-associated genes. Metabolic signatures 
related to the two main steps of energy production, glycolysis 
and oxidative phosphorylation, were more strongly induced by 
PIK3CAH1047R as compared with CTN NB1stab.
When we assessed cell type–specific transcriptional 
signatures (Merlos-Suárez et al., 2011), CTN NB1stab and 
PIK3CAH1047R both induced transiently amplifying cell-spe-
cific genes at the expense of differentiation-specific genes nor-
mally expressed in enterocytes. Yet only CTN NB1stab, and not 
PIK3CAH1047R, induced intestinal stem cell markers. Notably 
absent was the deregulation of genes implicated in the epithe-
lial–mesenchymal transition (EMT).
PIK3CAH1047R and CTN NB1stab play specific 
roles in the regulation of apoptosis, 
clonogenicity, and metabolic adaptation
In line with the transcriptome analysis, we found that 
CTN NB1stab- and PIK3CAH1047R-induced organoid cells prolif-
erated faster than controls. Induction of the oncoprotein com-
bination resulted in even faster proliferation, as assessed by 
cell count, DNA content, and quantification of crypt domains 
per organoid (Fig. 2 A).
To test for resistance to apoptosis, we passaged 
CTN NB1stab- and CTN NB1stab–PIK3CAH1047R-induced cultures 
as small cell clusters. Under these conditions, survival and out-
growth is limited by anoikis, a form of Rho kinase–dependent 
apoptosis (Sato et al., 2009). CTN NB1stab-induced cultures had 
a low colony-forming capacity compared with cultures pro-
ducing CTN NB1stab and PIK3CAH1047R (Fig. 2 B). Addition of 
the Rho kinase inhibitor Y-27632 during passage specifically 
increased the colony-forming capacity of CTN NB1stab cul-
tures. Thus, in agreement with the transcriptome analysis, the 
oncoprotein combination represses anoikis and promotes sur-
vival of intestinal cells.
We next assessed clonogenicity by reseeding single cell 
suspensions in the presence of Y-27632. In such assays, out-
growth is restricted to single cells maintaining stem cell traits 
in the absence of niche cells (Sato et al., 2011a). Limiting 
dilution assays showed that CTN NB1stab- and CTN NB1stab–
PIK3CAH1047R-induced cultures could be propagated by as few 
as 15 cells per well. In contrast, control and PIK3CAH1047R- 
induced organoids could not be propagated even when seeding 
150 individual cells per well (Fig.  2 C). Thus, PIK3CAH1047R 
cannot compensate for β-catenin activity in the maintenance of 
intestinal stem cell function.
We tested activities of key glycolytic enzymes in wild-
type cultures or after activation of the transgenes to follow up 
our finding of deregulated metabolic signatures. Aldolase and 
lactate dehydrogenase activities were reduced in CTN NB1stab- 
and compound oncogene–expressing cultures (Fig. 2 D). Lower 
expression of Aldob, coding for aldolase, was also observed in 
the transcriptomes of CTN NB1stab-induced and compound or-
ganoids. However, we were not able to detect changes in en-
zyme activities early after induction, probably because of lower 
fractions of induced cells at these time points (Fig. S2).
Levels of mitochondrial energy production, as assessed 
by a bioluminescence substrate conversion assay, were also af-
fected by the induction of the oncoproteins. Short-term (24 h) 
transgene induction already increased oxidative phosphoryla-
tion in the PIK3CAH1047R-producing and compound organoids, 
but not in CTN NB1stab-producing organoids (Fig.  2  E). This 
agrees with the signatures found in the transcriptomes. After 6 d 
of induction, increased oxidative phosphorylation was detected 
in all oncoprotein-producing models (Fig. S2), suggesting that 
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CTN NB1stab and PIK3CAH1047R 
synergistically control intestinal cell 
attachment and motility
We frequently observed colonies attaching to the surface of the 
culture dish in the double CTN NB1stab–PIK3CAH1047R-induced 
cultures. To enforce contact between outgrowing organoids and 
the plastic surface, we embedded organoids in diluted (50%) 
Matrigel (Fig. 3, A and B). CTN NB1stab–PIK3CAH1047R-induced 
organoids frequently attached, whereas expression of the other 
transgenes favored growth in the 3D matrix. Stabilization of 
β-catenin by the GSK3β inhibitor CHIR99021 augmented col-
ony attachment in single PIK3CAH1047R-induced cultures, pro-
viding evidence for synergistic roles of PI3K and β-catenin in 
regulating cell attachment.
We seeded organoids directly into a culture dish with 
CCM-EN in the absence of Matrigel (Fig. 3 C). CTN NB1stab- 
induced spheroids disintegrated and were strongly positive for 
cleaved caspase 3.  In contrast, CTN NB1stab–PIK3CAH1047R- 
Figure 1. Establishment and transcriptome analysis of intestinal organoids induced for CTN NB1stab and/or PIK3CAH1047R. (A) Schematic representation 
of transgenes used. ins, chicken β-globin 1.2-kb insulator; neo, neomycine phosphotransferase; pA, polyadenylation signal; PGK, phosphoglycerate 
kinase promoter; rtTA, reverse tetracycline-controlled transactivator; tdT, tdTomato; TRE, tet-responsive element. (B) Phenotypes of organotypic cultures ± 
R-spondin (R-Spo), as indicated. Top, brightfield (BF) images; bottom, tdTomato (tdT) fluorescence. Bar, 200 µm. (C–F) Transcriptome analysis. (C) Principal 
component analysis. Principal components PC1 and PC2 and an explained variation are given. Fluc, firefly luciferase. (D) Venn diagrams of CTN NB1stab- 
and PIK3CAH1047R-induced (C+P) and repressed genes, as indicated. (E) Cluster analysis of the 1,000 most variable genes. Gene ontology (GO) term 
enrichment for clusters is indicated in the box. Blue, low expression; red, high expression. (F) GSEA analysis of the transcriptomes. ISC, intestinal stem cell; 
MAPK, mitogen-activated protein kinase; TA, transiently-amplifying.
o
n





Published April 25, 2017
JCB • Volume 216 • NumBer 6 • 20171570
induced organoids grew out flat on the culture dish surface and 
were largely negative for cleaved caspase 3, demonstrating the 
antiapoptotic effect of additional PIK3CAH1074R. Attached col-
onies were stained uniformly positive for E-cadherin and nega-
tive for N-cadherin, indicating their epithelial character.
We used time-lapse microscopy to follow growth of CTN 
NB1stab and compound transgenic cultures in diluted Matri-
gel (Fig.  3  D and Videos 1, 2, and 3). CTN NB1stab-induced 
spheroids proliferated continuously at fixed positions within 
the 3D matrix and rarely fused. In contrast, CTN NB1stab–
PIK3CAH1047R-induced cultures showed a more complex be-
havior: First, as mentioned in the first section of Results and 
discussion, they displayed mixed organoid and spheroid pheno-
types. Second, they frequently fused while proliferating. Third, 
colonies attaching to the surface were highly motile. The 2D 
cell clusters collectively moved toward each other and fused to 
form larger colonies. In summary, the in vitro analyses indi-
cate that PIK3CAH1047R in combination with activated Wnt–β-
Figure 2. PIK3CAH1047R and CTN NB1stab play specific roles in the regulation of proliferation, apoptosis, clonogenicity, and metabolism. (A) Quantification 
of organoid proliferation, as indicated, after 4 d of induction. Cell numbers, DNA content, and crypt numbers are given. For the latter, bars and whiskers 
indicate median, 25th and 75th percentiles, and minimum/maximum values. (B) Passaging efficacy after disaggregation. Organoids per well after 4 d 
of outgrowth are given. (C) Clonogenicity after passaging of single cell suspensions. Organoids per well 8 d after seeding of 150 cells per well are 
given. (D) Quantification of key glycolytic enzyme activities in lysates of wild-type and long-term CTN NB1stab- or CTN NB1stab–PIK3CAH1047R-induced cul-
tures. C, CTN NB1stab; C+P, CTN NB1stab–PIK3CAH1047R. (E) Quantification of oxidative phosphorylation using a mitochondrial metabolic (MT) assay 24 h 
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catenin induces cell attachment, spreading, and motility in 
intestinal epithelial cells.
We tested CTN NB1stab–PIK3CAH1047R-induced cultures for 
chemotaxis and invasiveness through a porous membrane toward 
gradients of 10% FCS or the growth factors EGF and TGFα (both 
EGF receptor ligands), insulin-like growth factor (IGF; an IGF 
receptor ligand) or hepatocyte growth factor (binding the c-Met re-
ceptor), but we could detect neither (Fig. 3, E and F). We attribute 
the failure of CTN NB1stab–PIK3CAH1047R-induced intestinal cells 
to invade to a lack of chemotactic response to the growth factors and 
to their collective form of cell migration, which is likely incompati-
ble with invasion through outlets at the basal side of a cell cluster.
Figure 3. CTN NB1stab and PIK3CAH1047R synergize in the induction of epithelial cell attachment and motility. (A) Phenotypes of organotypic cultures induced 
for PIK3CAH1047R or CTN NB1stab–PIK3CAH1047R or treated with the GSK3β inhibitor CHIR99021 (CHIR). Blue arrowheads indicate colonies growing in 2D 
on the surface. Top rows, brightfield (BF) images; bottom rows, tdTomato (tdT) fluorescence. (B) Quantification of 2D colonies as per A. Bars and whiskers 
indicate median, 25th and 75th percentiles, and minimum/maximum values. Statistical analysis was obtained by two-tailed t test. *, P < 0.05; ***, P < 
0.0005. (C) Immunofluorescence images of CTN NB1stab or CTN NB1stab–PIK3CAH1047R-induced cultures using Alexa Fluor 488–labeled α–cleaved caspase 
3 (c-Caspase3) or α–E-cadherin antibodies. Brightfield and fluorescence channels are given. Nuclei are in blue. Red dashed lines demarcate edges of 
colonies. (D) Still images from time-lapse videos of organotypic cultures, as indicated. Top, brightfield images; bottom, confluence masks (CMs) showing 
areas with cells. Blue arrowheads indicate fusing colonies; red arrows indicate migrating cell clusters. Bars, 200 µm. (E and F) Quantification of transwell 
migration (E) and transwell invasion (F) assays. Red fluorescent object counts on the top in relation to the bottom of the porous membrane 4 d after the start 
of the assay. Graphs show means and SD of four assays. 
o
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Previous studies in CRC cell lines (Samuels et al., 2005) 
and mouse models (He et al., 2007; Leystra et al., 2012; Deming 
et al., 2014; Hare et al., 2014) found that oncogenic PIK3CA in 
conjunction with activated β-catenin can contribute to invasive-
ness. We conclude from our experiments that the CTN NB1stab 
and PIK3CAH1047R oncoproteins are not sufficient on their own 
to induce invasiveness or EMT in intestinal organoids.
Perturbation of the β-catenin–MAPK–PI3K 
network reveals the specific vulnerabilities 
of oncogene-induced organoid cultures
To assess the roles of specific nodes of the cell signaling net-
work in establishing cancer-associated organoid phenotypes, 
we used a panel of pharmaceutical inhibitors. These were di-
rected against MAPK kinase (MEK; AZD6244; Yeh et al., 
2007), Class I PI3K (GDC0941; Folkes et al., 2008), AKT 
(MK2206; Hirai et al., 2010), different activities of the mTOR 
complexes (rapamycin and Torin1; Thoreen and Sabatini, 
2009), and GSK3β (CHIR99021; Bennett et al., 2002; Ring 
et al., 2003; see Fig.  4  A for a network diagram). Inhibitors 
were used at concentrations that allowed survival of wild-type 
organoids for at least 3 d.
We quantified the colony-forming capacity of transgenic 
cultures in the presence of inhibitors. GDC0941 and rapa-
mycin specifically inhibited the outgrowth of CTN NB1stab- 
induced cultures but not of those expressing the combination 
with PIK3CAH1047R (Fig. 4 B). AZD6244 and Torin1 strongly 
blocked colony formation in both transgenic models. Our inhib-
itor assays suggest the existence of a transient sensitivity of ade-
nomatous cells exhibiting high β-catenin activity to rapamycin, 
in line with a previous finding in APC-deficient intestinal cells 
(Faller et al., 2014). We find here that resistance to rapamycin is 
restored by the acquisition of the PIK3CAH1047R mutation.
We also evaluated further phenotypes of the cultures 
(Fig.  4  C). Wild-type organoids displayed few discernible 
changes upon any inhibitor treatment except for CHIR99021, 
which mediated the formation of enlarged crypt domains. In 
contrast to CTN NB1stab-induced cultures, which generally 
Figure 4. Network perturbation analysis links oncogenic signal transduction to organoid survival. (A) Schematic representation of the cell signal trans-
duction network under investigation. Inhibitors are given in blue. Rapamycin specifically inhibits the mTORC1–S6K interaction, whereas Torin1 in addition 
inhibits the mTORC1–4EBP1 interaction and mTORC2 activities. Fz, Frizzled; RAF, rapidly accelerated fibrosarcoma; RAS, rat sarcoma. (B) Colony-forming 
capacity of wild-type, CTN NB1stab- or CTN NB1stab–PIK3CAH1047R-induced organotypic cultures in the presence of the indicated inhibitors. AZD, AZD6244; 
C, CTN NB1stab; C+P, CTN NB1stab–PIK3CAH1047R; CHIR, CHIR99021; GDC, GDC0941; MK, MK2206; Rapa, rapamycin; (C) Phenotypes of organotypic 
cultures in the presence of the indicated inhibitors or solvent control (indicated by dash). Bar, 200 µm. 
o
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formed spheroids without higher-order structures, double 
CTN NB1stab–PIK3CAH1047R cultures displayed a diverse array 
of phenotypes, as detailed in the first section of the Results and 
discussion. In the presence of MEK and PIK3CA inhibitors, 
spheroids formed preferentially, whereas inhibition of GSK3β 
favored the formation of 2D cell clusters.
Quantification of the β-catenin–MAPK–PI3K 
network reveals signaling nodes associated 
with phenotypic switches
To link states of the cell signaling network to oncoprotein ac-
tivities, we quantified proteins/phosphoproteins in control and 
long-term induced CTN NB1stab or CTN NB1stab–PIK3CAH1047R 
organoids and inhibitor treatments for 24 h (Fig. 5 A). Phos-
phorylation levels of key signaling nodes AKTS473, AKTT308, 
4EBP1T37/T46, S6S240/S244, GSK3βS9, extracellular signal-related 
kinase (ERK) 1T202/Y204 and ERK2T185/Y187 (ERK1/2T202/Y204), 
and MEK1/2S217/S221, and the abundance of two transcription 
regulators (β-catenin and c-Myc) were measured. Induction 
of CTN NB1stab alone did not significantly alter the phosphor-
ylation of the analyzed proteins. Induction of CTN NB1stab–
PIK3CAH1074R resulted in the phosphorylation of AKT, the 
direct AKT kinase target GSK3βS9, and the AKT-mTORC1 
target sites in 4EBP1 and S6 (see Fig. 4 A for a network dia-
gram; Cross et al., 1995; Song et al., 2012). Inhibitor treatment 
perturbed signal transduction and uncovered key features of the 
network: negative feedback from ERK to MEK (Dougherty et 
al., 2005; Fritsche-Guenther et al., 2011) was found regardless 
of oncogene activation, resulting in phospho-ERK depletion 
but phospho-MEK accumulation upon ADZ6244 treatment. 
We also observed bidirectional negative feedback between 
AKT and ERK (Rommel et al., 1999; Zimmermann and Mo-
elling, 1999; Fritsche-Guenther et al., 2016). Blockade of the 
PI3K–AKT axis by GDC0941 or MK2206 resulted in higher 
phosphorylation levels of ERK in CTN NB1stab-induced spher-
oids but not in normal organoids. Thus, AKT-to-ERK feedback 
appears to depend on oncogenic activation of β-catenin in in-
testinal cells. Inhibition of PI3K or AKT after induction of both 
oncoproteins expectedly reduced phosphorylation of the AKT 
target GSK3βS9 but unexpectedly did not abrogate phosphory-
lation in the downstream targets 4EBP1 and S6. It thus appears 
that AKT and mTORC1 can be uncoupled in this setting.
We found that CTN NB1stab- and CTN NB1stab–
PIK3CAH1047R-induced cultures, under most conditions, dis-
played higher levels of c-Myc, which is known to be a β-catenin 
target (He et al., 1998). However, the signal was at the lower 
detection limit in our capillary protein assays, precluding a 
meaningful interpretation across all conditions.
We finally correlated the protein/phosphoprotein analy-
ses with the cell phenotypes quantified as colony numbers and 
Figure 5. Network quantification identifies 4EBP1 and AKT as key nodes for colony outgrowth and cell motility. (A) Data matrix of protein/phosphopro-
tein and phenotypic analysis. For proteins/phosphoproteins, normalized linear values are given. Phenotypes are given as absolute numbers (colonies) 
or percent surface covered (2D growth). Dash indicates solvent control. (B) Pearson’s correlation matrix of protein/phosphoprotein and phenotypic data. 
Positive values (red) indicate positive correlation, negative values (blue) indicate anticorrelation. (C) Most relevant proteins/phosphoproteins for predicting 
phenotypes, as determined by Lasso. Also see Fig. S3.
o
n





Published April 25, 2017
JCB • Volume 216 • NumBer 6 • 20171574
2D outgrowth using Pearson’s correlation (Fig.  5  B). Colony 
formation and thus cell survival was best correlated with phos-
phorylation levels of 4EBP1 across all measurements. In con-
trast, cell attachment and motility was linked most strongly to 
AKT phosphorylation and only to a lesser extent to phosphory-
lation levels of 4EBP1 and GSK3β. Likewise, Lasso regression 
(Tibshirani, 1996) selected 4EBP1 and AKT as the phosphopro-
teins most strongly related to colony number and the formation 
of motile 2D colonies, respectively (Figs. 5 C and S3).
Our study links cancer-related phenotypes to the cell sig-
naling network in intestinal organoids. 4EBP1 has previously 
been identified as a converging point of MEK–ERK and PI3K–
AKT signals for cancer cell survival (She et al., 2010), and our 
analysis is in line with such a key role. We show that oncogenic 
β-catenin and PI3K activities interact in the acquisition of mul-
tiple cancer-related phenotypes in organoids grown in Matrigel. 
A more complex microenvironment composed of many matrix 
proteins and cell types could play unappreciated key roles in 
CRC in vivo to induce or repress further cancer phenotypes, 
such as invasion or EMT, in response to oncogenic signals 
(Bissell and Hines, 2011).
Materials and methods
Generation of transgenic mice
Transgene cassettes were constructed by linking tdTomato to human 
PIK3CAH1047R and/or murine stabilized mutant CTN NB1stab (S33A, 
S37A, T41A, and S45A) or firefly luciferase via 2A peptides and then 
subsequently cloning these gene combinations into a doxycycline-in-
ducible expression cassette. Transgenes contained a phosphoglycerate 
kinase promoter and were flanked by heterologous loxP and lox5171 
sites. Transgenes were integrated by Cre recombinase–mediated cas-
sette exchange into a previously modified Gt(ROSA)26Sor locus har-
boring a promoterless neomycin resistance gene in F1 hybrid B6/129S6 
embryonic stem cells (Fig. 1 A). Recombined clones were selected by 
250 µg/ml G418 and analyzed by Southern blotting of genomic DNA 
digested with BamH1 and HindIII, using the neomycin cassette as a 
probe (Vidigal et al., 2010). Animals were generated by diploid ag-
gregation, housed at a 12:12  h light/dark cycle, and fed ad libitum. 
Transgenes were induced by administration of 4 mg/ml doxycycline 
provided in a 5% sucrose solution via drinking water. Mouse lines were 
inbred to C57/BL6. Transgenic animal production and experimentation 
was approved by the Berlin State Office for Health and Social Affairs 
(G0185/09 and G0143/14).
Organoid culture and phenotypic analysis
Organoid cultures were initiated and propagated as described by Sato 
et al. (2011b) using 48-well plates with 15-µl droplets of medium and 
Matrigel (BD) per well overlaid with 300  µl CCM-REN. Crypt cul-
ture media were exchanged every other day. All comparisons between 
CTN NB1stab- and double CTN NB1stab–PIK3CAH1047R-induced cultures 
were done using CCM-EN + 2 µg/ml doxycycline. When we addi-
tionally used PIK3CAH1047R-producing organoids in functional assays, 
we cultured all models in the presence of R-spondin (CCM-REN + 
doxycycline), resulting in inconsistent transgene expression, i.e., the 
presence of a fraction of noninduced cells. Images of cultures were 
taken with a Biozero microscope using a Plan Fluor extra-long working 
distance DM 20× C 0.45 NA objective and Biozero observation and 
Analyser software (Keyence).
The following growth factors, inducers, and small-molecule in-
hibitors were used: EGF (50 ng/ml; PeproTech), insulin-like growth 
factor (100 ng/ml; PeproTech), hepatocyte growth factor (50 ng/ml; 
PeproTech), TGFα (10 ng/ml; PeproTech), noggin (100 ng/ml; Pe-
proTech); doxycycline (2 µg/ml; Sigma-Aldrich), Y-27632 (10  µM; 
Sigma-Aldrich), AZD6244 (10 µM; SelleckChem), GDC0941 (1 µM; 
SelleckChem), CHIR99021 (6  µM; SelleckChem), MK2206 (250 
nM; SelleckChem), rapamycin (100 nM; SelleckChem), and Torin1 
(4  µM; SelleckChem). Stocks were dissolved in either 70% EtOH 
(doxycycline), N-methyl-2-pyrrolidon (Torin1), or DMSO (all oth-
ers), and solvent concentrations were kept uniform across all wells 
in the experiments. Sublethal concentrations for inhibitors for cell 
signal transduction were determined in noninduced cultures. For sig-
nal inhibition experiments, inhibitors were added to already doxy-
cycline-induced cultures.
For quantification of organoid proliferation, cultures were in-
duced for 4 d. Cells were counted in well multiples after disaggregation 
using a Neubauer chamber. DNA content was determined using com-
ponents of the CellTox Green Cytotoxicity Assay (G8741; Promega) as 
given in the Metabolic assays section. For clonogenicity assays, 15 or 
150 cells per well were seeded into Matrigel domes in 48-well plates 
with CCM-REN + Y27632, and organoid colonies were counted after 
8 d. To systematically analyze the 2D attachment phenotype, cultures 
were disaggregated, seeded in 50% Matrigel onto precooled culture 
plates, and transferred to 37°C after 5 min. Time-lapse assays were 
performed in an Incucyte Zoom device (Essen Bioscience) using the 
10× objective and the phase contrast and red fluorescent channels. Or-
ganoid colony outgrowth and survival were quantified from time-lapse 
videos from >3 wells per condition, and only colonies that survived for 
4 d were counted. Colonies fusing during the examination period were 
counted as separate colonies. Transwell motility and invasion assays 
were performed with a Chemotaxis system (IncuCyte ClearView 96-
Well Chemotaxis Plate; 4582; Essen Bioscience) as per manufacturers’ 
application note. Wells were coated with 50 µg/ml Matrigel. Pore size 
of the transwell plates was 8 µM.
Protein analysis
For protein/phosphoprotein analysis from organoids, a WES capillary 
Western system (12–230 kD Master kit α-Rabbit–HRP; PS-MK01; 
Protein Simple) was used. In brief, organoids were collected in cold 
PBS and spun down, and Matrigel was removed. Organoids were taken 
up in 25-µl M-Per lysis buffer (78501; Thermo Fisher Scientific) sup-
plemented with phosphatase and proteinase inhibitors (PhosSTOP 
EASYpack phosphatase inhibitor cocktail tablets; 04906837001; and 
Complete EDTA-free phosphatase inhibitor tablets; 11873580001; 
Roche), left on ice for 30 min, and subsequently frozen at −80°C. After 
thawing, samples were sonicated and spun down, and the protein con-
tent of the supernatants was determined by bicinchoninic acid (BCA) 
assays. Depending on the size of the analyte, either cofilin or vincu-
lin were used to normalize the readout from each capillary. The fol-
lowing rabbit-derived antibodies were used: pAKTT308 (1:50; 2965), 
pAKTS473 (1:50; 9271), pGSK3βS9 (1:50; 9336), pS6RBS240/S244 (1:50; 
5364), p4EBP1T37/T46, (1:50; 2855), pERK1/2T202/Y204 (1:50; 9101), 
pMEK1/2S217/S221 (1:50; 9121), β-catenin (1:50; 9562), cofilin (1:50; 
5175), and vinculin (1:30; 4650; Cell Signaling Technology). c-Myc 
(1:50; ab32072) was purchased from Abcam. Three biological repli-
cates were used per condition.
For immunohistochemical stainings, tissues were fixed in 4% 
formaldehyde, dehydrated in a graded ethanol series, embedded in par-
affin, and sectioned at 4 µm. Sections were hydrated, antigens were 
retrieved by boiling in Tris-buffered 1.2  mM EDTA, pH 9.0, for 20 
min, and sections were blocked by 1% BSA in PBS. We used the fol-
lowing rabbit-derived antibodies: anti-KI67 (1:200; ab16667; Abcam), 
anti-RFP (1:200; 600-401-379; Rockland), and anti–cleaved caspase 
o
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3 (1:300; 9661; Cell Signaling Technology). Signals were detected 
using ImmPRE SS secondary antibodies and the NOVAred substrate 
kit (Vector Laboratories).
Immunofluorescent staining of CTN NB1stab and CTN NB1stab–
PIK3CAH1047R cultures was done from cultures growing for 2 d on mul-
tiwell slides (80826; Ibidi) in the absence of Matrigel. For microscopy, 
cultures were washed with PBS, fixed with 4% formaldehyde/PBS for 
15 min at room temperature, permeabilized with 0.5% Triton X-100/
PBS for 5 min, blocked with DMEM/10% FCS for 30 min, and incu-
bated with the first antibody diluted in 150 µl/well DMEM/10% FCS 
at 4°C in a wet chamber overnight. The following antibodies were 
used: anti–E-cadherin (1:250; 3195; Cell Signaling Technology), anti–
cleaved caspase 3 (1:400; 9664; Cell Signaling Technology), and goat 
anti–rabbit Alexa Fluor 488 (1:1,000; A11008; Thermo Fisher Scien-
tific). Images were taken with an LSM710 nonlinear optical AxioOb-
server microscope using a Plan-Apochromat 10× 0.3 M27 objective 
and Zen software (ZEI SS).
Metabolic analyses
Enzyme activity assays were determined from organoid cell extracts. 
Cells were collected in PBS supplemented with Complete Phos-
phatase Inhibitor Cocktail 2 and Phosphatase Inhibitor Cocktail 3 
(Sigma-Aldrich) and then were lysed by freezing. Samples were 
thawed and centrifuged for 10 min at 21,000 g at 4°C, and supernatant 
was used for the assays. All enzyme activities were measured in freshly 
prepared extracts at 37°C in a Synergy H4 plate reader (BioTek). Pro-
tein determinations were performed with the BCA Protein Assay kit 
(Thermo Fisher Scientific). A standard assay buffer containing 0.1 
Tris-HCl, pH 7.0, 15 mM NaCl, 0.5 mM CaCl, 140 mM KCl, and 
5 mM phosphate buffer, pH 7.0, was used. For all assays, the reaction 
mixtures without start reagents were prewarmed at 37°C. Composition 
of the reaction mixtures were as follows: hexokinase (enzyme com-
mission [EC] 2.7.1.1) – 10.5 mM MgSO4, 1.2 mM NADP+, 10 mM 
glucose, 1.75 U/ml glucose-6-phosphate dehydrogenase, and 10 mM 
ATP (the production of NAD PH was monitored over time by measur-
ing absorbance at 340 nm); phosphofructokinase 1 (EC 2.7.1.11) – 
1.5 mM MgSO4, 1.5 mM nicotinamide adenine dinucleotide (NADH), 
1 mM ATP, 0.5 U/ml aldolase, 0.3 U/ml glycerol-3-phosphate dehy-
drogenase, 0.9 U/ml triosephosphate isomerase, and 2 mM fructose 
6-phosphate (the consumption of NADH was monitored over time by 
measuring absorbance at 340 nm); aldolase (EC 4.1.2.13) – 0.5 mM 
MgSO4, 1.5 mM NADH, 0.3 U/ml glycerol-3-phosphate dehydroge-
nase, 0.9 U/ml triosephosphate isomerase, and 2  mM fructose 1,6- 
bisphosphate (the consumption of NADH was monitored over time 
by measuring absorbance at 340 nm); GAP DH (EC 1.2.1.12) – 1 mM 
DTT, 1.5 mM MgSO4, 1 mM ATP, 1.5 mM NADH, 22.5 U/ml 3-phos-
phoglycerate kinase, and 5 mM 3-phosphoglyceric acid (the consump-
tion of NADH was monitored over time by measuring absorbance 
at 340 nm); pyruvate kinase (EC 2.7.1.40) – 1.5 mM MgSO4, 1 mM 
ADP, 1 mM fructose 1,6-bisphosphate, 1.5 mM NADH, 50 U/ml lac-
tate dehydrogenase, and 2 mM phosphoenolpyruvate (the consump-
tion of NADH was monitored over time by measuring absorbance at 
340 nm); and lactate dehydrogenase (EC 1.1.1.27) – 0.5 mM MgSO4, 
1.5 mM NADH, and 1 mM pyruvate (the consumption of NADH was 
monitored over time by measuring absorbance at 340 nm. Four differ-
ent dilutions in PBS supplemented with the cocktails were analyzed 
to check for linearity.
Mitochondrial metabolic activity was measured using the Re-
alTime Glo MT Cell Viability Assay (G9711; Promega). In short, or-
ganoids were passaged the day before the assay into a black-walled 
96-well plate (3603; Corning). The next day, organoids were overlaid 
with 100 µl medium containing 0.1 µl NanoLuc enzyme, 0.1 µl MT Cell 
Viability Substrate, and 0.1 µl CellTox Green dye (G8741; Promega). 
Measurements of substrate conversion were performed using a Synergy 
2 microplate reader (BioTek) set to 37°C. Luminescence was measured 
for 1  s, and fluorescence excitation and emission wavelengths were 
485/20 and 528/20 nm, respectively. Measurements were done every 
hour, and mean values of three readouts were calculated. For normal-
ization by DNA content, 5 µl of lysis solution (component of CellTox 
Green Cytotoxicity Assay; G8741; Promega) were added to each well. 
The plate was measured after 1 h of incubation at 37°C and 5% CO2, 
and visual inspection was used for complete lysis.
RNA analysis
For RNA sequencing, organoids were induced for 24 h with 2 µg/ml 
doxycycline in CCM-REN medium. Fluorescence-activated cell sort-
ing of induced cell populations was done after dissociation in TrypLE 
(Gibco) and 100 U/µl DNaseI (Sigma-Aldrich) for 15 min at 37°C fol-
lowed by filtering through a 30-µM strainer (Costar) using an ARIA 
II Special Order Research Product (BD). Total RNA from sorted cells 
was extracted using the RNeasy Micro kit (QIA GEN), and 100 ng total 
RNA were used for library preparation with the ScriptSeq kit (Illu-
mina) according to the manufacturer’s instructions. 7–10 × 107 50-bp 
paired end reads per library were generated with a HiSeq 2500 se-
quencer (Illumina). Mapping and further processing is described in the 
next section. RNA-seq data are available in the GEO repository under 
accession no. GSE93947.
Olfm4 RNA in situ hybridization was performed on rehydrated 
paraffin sections using 800 ng/ml digoxigenin-labeled Olfm4 antisense 
probes. Signals were detected using anti–digoxigenin-Fab fragments 
coupled to alkaline phosphatase (1:1,000; Roche) and a nitro blue 
tetrazolium and 5-bromo-4-chloro-3′-indolyphosphate chromogenic 
reaction. Primer sequences flanking the in situ probe were Olfm4 _s, 
5′-GGA CCT GCC AGT GTT CTG TT-3′; and Olfm4_ as_T7, 5′-TAA 
TAC GAC TCA CTA TAG GGC CCC CAT TGT ACC AAT TCAC-3′.
Bioinformatics and statistical analyses
RNA-seq reads were aligned to the mouse genome GRCm38 using 
STAR aligner and Gencode exon annotations. Read counts were calcu-
lated for each gene ID using HTSeq. After removal of ribosomal reads, 
raw counts were normalized using the DESeq function EstimateSize-
Factors, and dispersion in replicates was calculated using the DESeq 
function EstimateDispersions with default parameters. After removing 
lowly expressed genes with mean read counts below 64, data were 
log2 transformed, and the top 1,000 varying genes were selected by 
dividing the overall SD by the mean relative SD estimated by DESeq. 
K-means clustering was performed in R (nstart = 100 liters; max = 
100) with six centers on genewise z-normalized expression of the 
top 1,000 varying genes. GSEA was done as previously described by 
Subramanian et al. (2005). Signatures are referenced in the main text 
or were taken from the Broad Institute Hallmark signature collection 
(Liberzon et al., 2015).
For correlation analyses, we computed the median of repeated 
protein and phosphoprotein measurements and set undetectable lev-
els to 0.  In total, nine proteins/phosphoproteins and two phenotypic 
responses were measured for 21 different conditions, corresponding 
with three oncogenic states and seven drug perturbations. To investi-
gate the relationship between signaling state and phenotypic response 
as well as between individual proteins/phosphoproteins, we first com-
puted the Pearson’s correlation matrix between all measured entities 
for logarithmized (log(1 + x)) data. Next, to find a direct relationship 
between signaling state and phenotypic response, we used Lasso mod-
eling (Tibshirani, 1996) to fit a linear model from the logarithmized and 
normalized protein/phosphoprotein data to phenotypic data. By using 
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an increasing penalty term for the linear model coefficient, proteins/
phosphoproteins were ranked according to their importance.
Pairwise data comparisons were done using two-tailed t tests in 
Prism (GraphPad Software). For all figures, the following p-value cut-
offs were used: *, P < 0.05; **, P < 0.005; ***, P < 0.0005. In cases 
where a range is given, we used the SD. For all parametric tests, we 
assumed normal data distribution, but this was not formally tested.
Online supplemental material
Fig. S1 shows synergy of CTN NB1stab and PIK3CAH1047R in inducing 
intestinal epithelial proliferation in vivo. Fig. S2 shows metabolic ac-
tivities in intestinal organoids after the induction of transgenes. Fig. S3 
shows LAS SO fits for both numbers of colonies and colony attachment. 
Video 1 shows noninduced organoid cultures embedded in 50% Matri-
gel. Video  2 shows CTN NB1stab-induced cultures embedded in 50% 
Matrigel. Video 3 shows CTN NB1stab–PIK3CAH1047R-induced cultures 
embedded in 50% Matrigel.
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